99mTc-TRODAT-1 SPECT/CT与18F-FDOPA PET/CT在帕金森病、帕金森叠加综合征及特发性震颤中的性能比较
该前瞻性研究纳入103例患者(PD 48例、PPS 19例、ET 36例),比较99mTc-TRODAT-1 SPECT/CT与18F-FDOPA PET/CT检测突触前多巴胺能功能障碍的性能。两种显像在检测突触前多巴胺能功能障碍方面具有实质性一致性(加权κ=0.659),纹状体特异性摄取比(SUR)在SPECT与PET间显著相关(r=0.67,P<0.01),且两者均有助于区分早期PD/PD和PPS与ET。
要点
- ET组双侧纹状体呈对称逗号形摄取,平均SUR显著高于早期PD(H&Y I-II期,n=37)、PD和PPS(SPECT与PET均P≤0.001)。
- PD与PPS组间平均SUR无显著差异(SPECT P=0.17;PET P=0.61)。
- 99mTc-TRODAT-1与18F-FDOPA检测突触前多巴胺能功能障碍具有实质性一致性(加权κ=0.659)。
核心结论
- 99mTc-TRODAT-1 SPECT/CT与18F-FDOPA PET/CT在检测多巴胺能功能障碍方面具有实质性一致性,均为潜在影像生物标志物,有助于区分早期PD/PD和PPS与ET。
研究设计与样本
- 前瞻性研究纳入103例患者,其中PD 48例、PPS 19例、ET 36例,均行99mTc-TRODAT-1 SPECT/CT与18F-FDOPA PET/CT脑扫描。
- 对PD和PPS病例进行Hoehn and Yahr(H&Y)分期和MDS-UPDRS评估,扫描结果行视觉和半定量分析。
- SPECT计算平均像素计数、PET计算纹状体SUVmean,分别用于计算纹状体特异性摄取比(SUR)。
主要发现
- ET病例双侧纹状体呈对称逗号形摄取,平均SUR显著高于早期PD(H&Y I和II期,n=37)、PD和PPS,SPECT与PET图像均P≤0.001。
- PD与PPS组间平均SUR无显著差异(SPECT P=0.17;PET P=0.61)。
- 99mTc-TRODAT-1与18F-FDOPA检测突触前多巴胺能功能障碍具有实质性一致性(加权κ=0.659)。
- SPECT与PET的纹状体SUR相关性有统计学意义(r=0.67;P<0.01)。
- SUR与H&Y分期/MDS-UPDRS呈负相关但无统计学意义。
关键数值与推荐
- ET组平均SUR显著高于早期PD(H&Y I和II期,n=37)、PD和PPS,SPECT与PET均P≤0.001。
- PD与PPS组间平均SUR比较:SPECT P=0.17,PET P=0.61。
- 两种显像检测突触前多巴胺能功能障碍的加权κ=0.659。
- SPECT与PET的纹状体SUR相关系数r=0.67,P<0.01。
临床怎么用
- 99mTc-TRODAT-1 SPECT/CT与18F-FDOPA PET/CT均可作为检测多巴胺能功能障碍的潜在影像生物标志物。
- 两种显像有助于区分早期PD/PD和PPS与ET病例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of this study was to assess the utility of presynaptic dopaminergic imaging using 99mTc-TRODAT-1 SPECT/CT and 18F-FDOPA PET/CT and compare their performance in Parkinson's disease (PD), Parkinson-plus syndrome (PPS), and essential tremor (ET). PATIENTS AND METHODS: A total of 103 patients (PD = 48, PPS = 19, and ET = 36) were enrolled prospectively. Hoehn and Yahr (H&Y) staging and MDS-UPDRS (Movement Disorder Society-Sponsored Revision of Unified Parkinson's Disease Rating Scale) were done for PD and PPS cases. All the patients underwent 99mTc-TRODAT-1 SPECT/CT and 18F-FDOPA PET/CT brain scan. The scans were analyzed visually and semiquantitatively. Average pixel count and SUVmean of the striatum were calculated in SPECT and PET images, respectively, to calculate the specific uptake ratio of striatum (SUR). Comparison of scan findings and SURs among different groups and correlation with clinical characteristics was done. RESULTS: Symmetrical comma-shaped uptake was seen in bilateral striatum in ET cases with mean SURs significantly higher than in cases of early PD (H&Y stage I and II, n = 37), PD and PPS both on SPECT and PET images (P ≤ 0.001). The mean SURs between PD and PPS showed no significant difference (SPECT, P = 0.17; PET, P = 0.61). Substantial agreement (weighted κ = 0.659) was found between 99mTc-TRODAT-1 and 18F-FDOPA for the detection of presynaptic dopaminergic dysfunction. Specific uptake ratio of striatum correlation between SPECT and PET was statistically significant (r = 0.67; P < 0.01). A negative but nonsignificant correlation was found between the SURs and H&Y staging/MDS-UPDRS. CONCLUSIONS: Both 99mTc-TRODAT-1 SPECT/CT and 18F-FDOPA PET/CT showed substantial agreement and proved to be potential imaging biomarker for the detection of dopaminergic dysfunction, thus assisting in differentiating early PD/PD and PPS from ET cases.
引用
- Sood A, Shukla J, Shree R, et al. Comparative Performance of 99mTc-TRODAT-1 SPECT/CT and 18F-FDOPA PET/CT Imaging in Patients With Parkinson's Disease, Parkinson-Plus Syndrome, and Essential Tremor. Clin Nucl Med. 2021. PMID: 33234920. doi:10.1097/RLU.0000000000003409
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。